Literature DB >> 11848446

Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.

Mike Greaves1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11848446

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  14 in total

1.  Toward development of a point-of-care assay of enoxaparin anticoagulant activity in whole blood.

Authors:  Mario A Inchiosa; Suryanarayana Pothula; Keshar Kubal; Vajubhai T Sanchala; Iris Navarro
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

Review 2.  Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?

Authors:  H M Oudemans-van Straaten; J P J Wester; A C J M de Pont; M R C Schetz
Journal:  Intensive Care Med       Date:  2006-02-02       Impact factor: 17.440

Review 3.  What are the anticoagulation options for intermittent hemodialysis?

Authors:  Andrew Davenport
Journal:  Nat Rev Nephrol       Date:  2011-07-05       Impact factor: 28.314

4.  Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experience.

Authors:  John Quinn; Kate Von Klemperer; Ruth Brooks; Donald Peebles; Fiona Walker; Hannah Cohen
Journal:  Haematologica       Date:  2009-11       Impact factor: 9.941

Review 5.  Pharmacokinetics, efficacy, and safety of LMWHs in venous thrombosis and stroke in neonates, infants and children.

Authors:  U Nowak-Göttl; C Bidlingmaier; A Krümpel; L Göttl; G Kenet
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

Review 6.  Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments.

Authors:  Andrew Davenport
Journal:  Pediatr Nephrol       Date:  2012-02-29       Impact factor: 3.714

Review 7.  Renal replacement therapy in acute kidney injury: controversy and consensus.

Authors:  Claudio Ronco; Zaccaria Ricci; Daniel De Backer; John A Kellum; Fabio S Taccone; Michael Joannidis; Peter Pickkers; Vincenzo Cantaluppi; Franco Turani; Patrick Saudan; Rinaldo Bellomo; Olivier Joannes-Boyau; Massimo Antonelli; Didier Payen; John R Prowle; Jean-Louis Vincent
Journal:  Crit Care       Date:  2015-04-06       Impact factor: 9.097

8.  Monitoring low molecular weight heparins at therapeutic levels: dose-responses of, and correlations and differences between aPTT, anti-factor Xa and thrombin generation assays.

Authors:  Owain Thomas; Emanuel Lybeck; Karin Strandberg; Nahreen Tynngård; Ulf Schött
Journal:  PLoS One       Date:  2015-01-27       Impact factor: 3.240

Review 9.  Clinical review: Patency of the circuit in continuous renal replacement therapy.

Authors:  Michael Joannidis; Heleen M Oudemans-van Straaten
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 10.  Anticoagulant therapy in pediatrics.

Authors:  Mariam K Dabbous; Fouad R Sakr; Diana N Malaeb
Journal:  J Basic Clin Pharm       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.